Unum Group (NYSE:UNM) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 2.4 by 10 Brokerage Firm. 2 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating. 6 Brokerage Firms have advised hold.
Unum Group (NYSE:UNM): The stock price is expected to reach $ 37.56 in the short term. The number of analysts agreeing with this consensus is 9. The higher estimate for the short term price target is at $41 while the lower estimate is at $31. The standard deviation of the price stands at $2.88.
Unum Group (NYSE:UNM) rose 0.7% or 0.24 points on Tuesday and made its way into the gainers of the day. After trading began at $34.3 the stock was seen hitting $34.48 as a peak level and $34.01 as the lowest level. The stock ended up at $34.4. The daily volume was measured at 1,826,508 shares. The 52-week high of the share price is $38.15 and the 52-week low is $23.99. The company has a market cap of $8,179 million.
Shares of Unum Group appreciated by 1.47% during the last five trading days but lost 2.99% on a 4-week basis. Unum Group is up 7.82% in the last 3-month period. Year-to-Date the stock performance stands at 4.6%.
Unum Group is a provider of disability insurance products in the United States and the United Kingdom. The Companys business segments: Unum US, Unum UK, Colonial Life, Closed Block and Corporate. Unum US includes group long-term and short-term disability insurance, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business. Unum UK includes insurance for group long-term disability, group life and lines of business, which include individual disability and critical illness products. Colonial Life includes insurance for accident, sickness, and disability products, life products, and cancer and critical illness products to employees. The Companys Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. Its Corporate segment includes investment income on corporate assets not specifically allocated to a line of business.